I just heard that there is a chance that Agilent’s Emily Le Proust, R&D Director overseeing development of SureSelect, will be giving a seminar in Stockholm next week. I don’t have details other than that, since the details are being finalized. There is some chance it might not happen. However, since SureSelect genomic target enrichment is of interest to many researchers in Next Generation Sequencing (NGS), I thought I would give a “heads up.”
You are welcome to contact me if you are interested in learning some more.
(Information has been updated since this post was first made)